Viewing StudyNCT00386373



Ignite Creation Date: 2024-05-05 @ 5:06 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00386373
Status: COMPLETED
Last Update Posted: 2012-08-01
First Post: 2006-10-09

Brief Title: Use and Tolerability of Imatinib Mesylate Gleevec in Leukemia Patients
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
SCT View
Chronic Myeloid Leukemia View
CML View
ALL View
AML View
Leukemia View
Imatinib Mesylate View
Gleevec View
Philadelphia-Positive View
Bone marrow transplant View
BMT View
Stem cell transplant View